Discngine X Nanome:
Maximizing Structure-Based Drug Design with In-Depth Structural Insights and Virtual Reality
We are excited to invite you to Discngine’s in-person event in Basel, with Nanome to discuss how in-depth structural insights and virtual reality can maximize your structure-based drug design.
The 3D protein structure space is expanding rapidly, driven by advancements in experimental and AI technologies. While such a wealth of structural data presents immense potential for rational drug design, efficient data management and collaboration in SBDD have become challenging.
Join our event to discover modern technologies that reveal the full potential of structural data with a high level of collaboration for efficient structure-guided idea generation. You will discover innovative solutions and strategies from Discngine and Nanome that enable you to:
Centralize structural knowledge and perform in-depth analysis for structure-based drug design
Immerse into a Virtual Reality environment to leverage data visualization, communication, and collaboration
Seamlessly integrate both technologies for enhanced data-driven decision-making
The Speakers
Lorena Zara, Ph.D
Scientific Project Manager at Discngine
Roberta Bartolotta, PharmD, Ph.D, PMP
Account Executive / Application Scientist - Medicinal Chemistry at Nanome